“%SUNLOC SHL/SEC/ 11.11.2016 To, ‘The Manager, Bombay Stock Exchange Ltd. Dept. of Corporate Service PJ Towers, Dalal Street, ‘Mumbai-400001 Scrip Code: - 537253 Sub: Submission of Un-audited Financial Result for the quarter and half year ended 30.09.2016 under Regulation 30 & 33 of SEBI (Listing Regulation and Disclosure Requirement) Regulation, 2015 Dear Sir, Please find enclosed herewith the Un- audited Financial Result for the quarter and half year ended 30.09.2016 in Compliance of Regulation 30 read with 33 of SEBI (Listing Regulation and Disclosure Requirement) Regulation, 2015 duly approved by the Board of Directors of the Company in their meeting held on Friday, 11" November, 2016 alongwith Limited Review Report. The meeting was commencement at 4.00 P.M. and concluded at 6.00 P.M Kindly take the same on record. Thanking you. Your Faithfully For Sunil Healthcare Limited ‘Company Secretary CC- Caleutta Stock Exchange Ltd, 7, Lyoris Range Kolkata- 700 001 Sunil Healthcare Limited~ rm $e NATED ILO cn. vn Te ps B06) [iment tri ueeve| zeae) sani] cain] asnse| gate la fnsoecrneh ose mas ‘mie| sane] Gree] Sera 1 Seem pom] ames] asus) ast] ama] anos 3 rtm aay itr a man acn| sess] an] air] aaa |, ome Soo) eae] om] aa] eae| ns 3 cto ers mrt and 17 ange ret oto sere, a ee | Sa P oeeecrecee saz] ga] cae] wan] see = SEL GSE] wif) Gs] issintement of et ad Labi Sanne (rita faiswecret| ora oss (hr auras aot Rowse 2 She sppcaon one pending attest tetonTerboronings sane nese (tetas ot ‘beer mos Fares pon nos joss Sst nowcaret abies rans 33300 [aston tem boremnes ag0eas uso (nnd Ae (ol onete or ane advance an Subtotal non caret ane aps (het yeni saiesr (Ghcam ender eset ise ‘eon {ower curenenes san sot sorausassre Some ssrass faeSinghi & Co. Chartered Accountants 402-403, Pragali House, 47-48, Nehru Place, New Delhi-110 019 (India) Ph. : (011) 30820179, 30820180, 41018091 ‘e-mail : newdelhi@singhico.com Website : www.singhico.com Limited Review Report ‘To the Board of Directors of Sunil Healthcare Limited We have reviewed the accompanying statement of unaudited financial results of Sunil Healtheare Limited for the quarter and half year ended 30" September '2016. This statement is the responsibility of the Company’s Management and has been approved by the Board of Directors. Our responsibility is to issue a report on these financial statements based on our review. ‘We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity issued by the Institute of Chartered Accountants of India, This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inguiries of company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable accounting standards and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement, For Singhi & Co, Chartered Accotintants Firm Registration No. 302049E BK. Sipani Place: New Delhi ’ Partner Date: 11" November ‘2016 Membership No. 088926 Mb ——